EXACT Sciences Valuation
| EXAS Stock | USD 45.70 0.78 1.74% |
At this time, the firm appears to be overvalued. EXACT Sciences owns a latest Real Value of $40.71 per share. The recent price of the firm is $45.7. Our model computes the value of EXACT Sciences from analyzing the firm fundamentals such as Current Valuation of 10.11 B, return on asset of -0.0187, and Shares Outstanding of 185.76 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that EXACT Sciences' price fluctuation is very steady at this time. Calculation of the real value of EXACT Sciences is based on 3 months time horizon. Increasing EXACT Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the EXACT stock is determined by what a typical buyer is willing to pay for full or partial control of EXACT Sciences. Since EXACT Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EXACT Stock. However, EXACT Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 45.7 | Real 40.71 | Hype 45.7 | Naive 46.11 |
The intrinsic value of EXACT Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EXACT Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of EXACT Sciences helps investors to forecast how EXACT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EXACT Sciences more accurately as focusing exclusively on EXACT Sciences' fundamentals will not take into account other important factors: EXACT Sciences Total Value Analysis
EXACT Sciences is currently forecasted to have valuation of 10.11 B with market capitalization of 8.34 B, debt of 2.75 B, and cash on hands of 728.04 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the EXACT Sciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.11 B | 8.34 B | 2.75 B | 728.04 M |
EXACT Sciences Investor Information
About 99.0% of the company shares are held by institutions such as insurance companies. The book value of EXACT Sciences was currently reported as 12.94. The company recorded a loss per share of 5.59. EXACT Sciences had not issued any dividends in recent years. Based on the key indicators related to EXACT Sciences' liquidity, profitability, solvency, and operating efficiency, EXACT Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.EXACT Sciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. EXACT Sciences has an asset utilization ratio of 46.54 percent. This implies that the Company is making $0.47 for each dollar of assets. An increasing asset utilization means that EXACT Sciences is more efficient with each dollar of assets it utilizes for everyday operations.EXACT Sciences Ownership Allocation
The majority of EXACT Sciences outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to obtain positions in EXACT Sciences to benefit from reduced commissions. Thus, outside corporations are subject to a different set of regulations than regular investors in EXACT Sciences. Please pay attention to any change in the institutional holdings of EXACT Sciences as this could imply that something significant has changed or is about to change at the company.EXACT Sciences Profitability Analysis
The company reported the previous year's revenue of 2.76 B. Net Loss for the year was (1.03 B) with profit before overhead, payroll, taxes, and interest of 1.92 B.About EXACT Sciences Valuation
The stock valuation mechanism determines EXACT Sciences' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of EXACT Sciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of EXACT Sciences. We calculate exposure to EXACT Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EXACT Sciences's related companies.Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 6420 people.
EXACT Sciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as EXACT Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 184.2 M | |
| Forward Price Earnings | 2500 |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.